Log in
NASDAQ:OPRX

OptimizeRx Stock Forecast, Price & News

$25.05
+1.08 (+4.51 %)
(As of 11/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$23.72
Now: $25.05
$25.61
50-Day Range
$19.04
MA: $21.62
$25.05
52-Week Range
$6.50
Now: $25.05
$25.60
Volume149,461 shs
Average Volume131,087 shs
Market Capitalization$378.48 million
P/E RatioN/A
Dividend YieldN/A
Beta0.56
OptimizeRx Corporation operates as a digital health company that facilitates communication at point-of-care among various stakeholders in healthcare. Its cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, and critical clinical information; and network consists of electronic health record company platforms, which provide the ambulatory patient market with access to their workflow at the point-of-care. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and clinical messaging services. The company's products and applications also comprise brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, it operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform that allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, the company offers patient programs with treatment and affordability information, lifestyle and condition trackers, Internet device connectivity, forms, and surveys. OptimizeRx Corporation is headquartered in Rochester, Michigan.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.49 out of 5 stars


Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
Current SymbolNASDAQ:OPRX
CUSIPN/A
CIKN/A
Phone248-651-6568
Employees70

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$24.60 million
Book Value$3.17 per share

Profitability

Net Income$-3,140,000.00

Miscellaneous

Market Cap$378.48 million
Next Earnings Date2/25/2021 (Estimated)
OptionableNot Optionable
$25.05
+1.08 (+4.51 %)
(As of 11/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OPRX News and Ratings via Email

Sign-up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











OptimizeRx (NASDAQ:OPRX) Frequently Asked Questions

How has OptimizeRx's stock been impacted by COVID-19 (Coronavirus)?

OptimizeRx's stock was trading at $7.51 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, OPRX stock has increased by 233.6% and is now trading at $25.05.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of OptimizeRx?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OptimizeRx in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for OptimizeRx
.

What stocks does MarketBeat like better than OptimizeRx?

Wall Street analysts have given OptimizeRx a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but OptimizeRx wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is OptimizeRx's next earnings date?

OptimizeRx is scheduled to release its next quarterly earnings announcement on Thursday, February 25th 2021.
View our earnings forecast for OptimizeRx
.

How were OptimizeRx's earnings last quarter?

OptimizeRx Co. (NASDAQ:OPRX) issued its quarterly earnings results on Monday, November, 9th. The company reported $0.07 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.04 by $0.03. OptimizeRx had a negative net margin of 23.79% and a negative return on equity of 14.44%.
View OptimizeRx's earnings history
.

What guidance has OptimizeRx issued on next quarter's earnings?

OptimizeRx updated its third quarter 2020 Pre-Market earnings guidance on Tuesday, October, 13th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $10 million, compared to the consensus revenue estimate of $9.1 million.

What price target have analysts set for OPRX?

4 analysts have issued 1-year target prices for OptimizeRx's stock. Their forecasts range from $26.00 to $40.00. On average, they expect OptimizeRx's stock price to reach $33.33 in the next twelve months. This suggests a possible upside of 33.1% from the stock's current price.
View analysts' price targets for OptimizeRx
.

Who are some of OptimizeRx's key competitors?

What other stocks do shareholders of OptimizeRx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OptimizeRx investors own include InterDigital (IDCC), Bank of Hawaii (BOH), NVIDIA (NVDA), STAG Industrial (STAG), Etsy (ETSY), Marvell Technology Group (MRVL), The Trade Desk (TTD), Verizon Communications (VZ), Advanced Micro Devices (AMD) and Amgen (AMGN).

Who are OptimizeRx's key executives?

OptimizeRx's management team includes the following people:
  • Mr. William J. Febbo, CEO & Director (Age 51, Pay $442.19k)
  • Ms. Miriam J. Paramore, Pres (Age 57, Pay $331.75k)
  • Mr. Douglas P. Baker, Chief Financial Officer (Age 63, Pay $318.93k)
  • Mr. Stephen L. Silvestro, Chief Commercial Officer (Age 42, Pay $271.5k)
  • Mr. Todd Inman, Chief Technology Officer
  • Mr. Terence J. Hamilton, Sr. VP of Pharma (Age 55)
  • Mr. Srdjan Loncar, Head of Patient Engagement Solutions
  • Ms. Rebecca Whitney, Sr. VP of Commercial Operations
  • Ms. Heather Favazza, Controller
  • Mr. James Brooks, Consultant (Age 51)

What is OptimizeRx's stock symbol?

OptimizeRx trades on the NASDAQ under the ticker symbol "OPRX."

Who are OptimizeRx's major shareholders?

OptimizeRx's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.32%), AWM Investment Company Inc. (6.01%), Blair William & Co. IL (5.16%), Avenir Corp (4.83%), Wasatch Advisors Inc. (3.04%) and Handelsbanken Fonder AB (2.58%). Company insiders that own OptimizeRx stock include Awm Investment Company, Inc, Douglas P Baker, Ellen O'connor Vos, Gregory D Wasson, Gus D Halas, Miriam J Paramore and William J Febbo.
View institutional ownership trends for OptimizeRx
.

Which institutional investors are selling OptimizeRx stock?

OPRX stock was sold by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., P.A.W. Capital Corp, AWM Investment Company Inc., Fifth Third Bancorp, S Squared Technology LLC, BlackRock Inc., Avenir Corp, and Wells Fargo & Company MN.
View insider buying and selling activity for OptimizeRx
.

Which institutional investors are buying OptimizeRx stock?

OPRX stock was bought by a variety of institutional investors in the last quarter, including Handelsbanken Fonder AB, Venator Capital Management Ltd., Perkins Capital Management Inc., Morgan Stanley, Handelsinvest Investeringsforvaltning, Blair William & Co. IL, Harel Insurance Investments & Financial Services Ltd., and Trexquant Investment LP. Company insiders that have bought OptimizeRx stock in the last two years include Ellen O'connor Vos, Gregory D Wasson, Gus D Halas, Miriam J Paramore, and William J Febbo.
View insider buying and selling activity for OptimizeRx
.

How do I buy shares of OptimizeRx?

Shares of OPRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is OptimizeRx's stock price today?

One share of OPRX stock can currently be purchased for approximately $25.05.

How big of a company is OptimizeRx?

OptimizeRx has a market capitalization of $378.48 million and generates $24.60 million in revenue each year. The company earns $-3,140,000.00 in net income (profit) each year or ($0.19) on an earnings per share basis. OptimizeRx employs 70 workers across the globe.

What is OptimizeRx's official website?

The official website for OptimizeRx is www.optimizerx.com.

How can I contact OptimizeRx?

OptimizeRx's mailing address is 400 WATER STREET SUITE 200, ROCHESTER MI, 48307. The company can be reached via phone at 248-651-6568 or via email at [email protected]

This page was last updated on 11/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.